Search

Obtenga más información sobre el primer centro en el mundo dedicado a las necesidades específicas de los pacientes con cáncer colorrectal menores de 50 años.

… Monday, March 8, 2021 Resumen Un aumento preocupante de casos de cáncer colorrectal entre los adultos más jóvenes ha llevado a los expertos a sugerir que se publiquen nuevas pautas que reduzcan la edad recomendada en que las personas deben comenzar a hacerse las pruebas de detección colorrectal de los

Local control rates and overall survival (OS) were significantly higher for patients with brain metastases treated with adjuvant stereotactic radiosurgery (SRS) within two months of resection, compared to longer time intervals, according to our new study published recently in Neuro-Oncology Practice.

… Thursday, September 23, 2021 Local control rates and overall survival (OS) were significantly higher for patients with brain metastases treated with adjuvant stereotactic radiosurgery (SRS) within two months of resection, compared to longer time intervals, according to our new study published recently

A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer.

… Wednesday, December 23, 2020 A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer. In a recent issue of the  New England Journal of Medicine , results from the phase III study — Keynote 177 — provided further

一项由纪念斯隆凯特琳的医生-研究人员部分主导的具有里程碑意义的研究给部分转移性结直肠癌患者带来新的希望。

… Wednesday, December 23, 2020 一项由纪念斯隆凯特琳的医生-研究人员部分主导的具有里程碑意义的研究给部分转移性结直肠癌患者带来新的希望。 在最近一期的 《新英格兰医学杂志》 上，III 期研究 (Keynote 177) 的结果提供了进一步相关证据，证明当用作一线治疗时， 免疫治疗 药物帕博利珠单抗 可改善不可切除及微卫星不稳定性-高 (MSI-H) /错配修复缺陷 (dMMR) 转移性结直肠癌患者的疾病进展。 今年 6 月，帕博利珠单抗获得 FDA 突破性疗法的认定 ，用于该亚组患者的治疗。 大约 5% 的转移性结直肠癌患者患有 MSI-H/dMMR 类型的疾病。 在癌症中

The Starr Foundation is continuing its longstanding commitment to stem cell research in New York City with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), a research collaboration between Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine.

… Thursday, April 4, 2019 The Starr Foundation is continuing its longstanding commitment to stem cell research in New York City with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), a research collaboration between Memorial Sloan Kettering Cancer Center, The Rockefeller

Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.

… Monday, December 8, 2025 If you or a loved one is facing cancer, you may wish you could regain some sense of control when so much feels beyond your power. You may wonder what you can or should eat. Comfort food? Healthy food? How much does it matter? The effort at Memorial Sloan Kettering Cancer Center

New MSK research marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; uncovers how changes to “helper” proteins drive cancer cell survival; develops a new model for investigating lung cancer metastasis; and uses AI to improve outcome predictions in sarcoma.

… Wednesday, November 6, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health

Meghan Winston chose Memorial Sloan Kettering Cancer Center to surgically remove her stomach—called a total gastrectomy—to protect against a deadly form of stomach cancer caused by a rare mutation in the CDH1 gene.

… Wednesday, July 13, 2022 Meghan and Ryan Meghan Winston (right) with her fiancée Ryan Ferri. Meghan’s stomach was surgically removed at Memorial Sloan Kettering Cancer Center, to prevent the high risk she would develop a deadly stomach cancer due to a rare genetic mutation called CDH1. “I was scared

According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan- Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly set the disease apart not only from other types of ovarian cancer, but from other solid tumors as well.

… Wednesday, June 29, 2011 According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer , researchers from Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly

Find answers about rectal bleeding, including hemorrhoids and cancer, from an MSK specialist.

… Wednesday, March 4, 2026 If you notice blood in your stool or when you wipe, it’s natural to feel worried — and maybe a little embarrassed to tell anyone, even your doctor. But it’s important to recognize when something isn’t right and to know when you should speak to a healthcare provider.  “Talking